Company intelligence / Profile preview
Simcere Zaiming Pharmaceutical
Nanjing, Jiangsu, China
- Ownership
- Private
- Employees
- ~6815
- Development stage
- Other
01
Overview
Simcere Zaiming Pharmaceutical is an oncology-focused biopharmaceutical subsidiary of Simcere Pharmaceutical Group. The company has a diverse portfolio of approved innovative drugs in China, including Enzeshu (suvisexumab), COSELA (trilaciclib), and Enweida (envafolimab). Its clinical pipeline is characterized by multi-specific antibodies and ADCs, featuring high-value global partnerships with AbbVie, Ipsen, and NextCure. In early 2026, the company announced the successful dosing of patients in Phase 1 trials for advanced programs like its bispecific ADC SIM0610 and reported positive early results for its PD-L1/IL-15 fusion protein SIM0237.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyAntibody-drug conjugateSmall moleculeRecombinant proteinTrispecific antibodyBispecific antibodyBispecific antibody-drug conjugateRecombinant fusion protein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
AbbVieIpsenNextCurePyxis OncologyG1 Therapeutics3D MedicinesAlphamab OncologyTargetRx
Beyond the preview
Go deeper on Simcere Zaiming Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Simcere Zaiming Pharmaceutical.